Marvin H. Caruthers

Distinguished Professor of Chemistry & Biochemistry at The University of Colorado

Marvin H. Caruthers

Marvin H. Caruthers

Distinguished Professor of Chemistry & Biochemistry at The University of Colorado

Overview
Career Highlights

miRagen Therapeutics, Inc. (Inactive)
Applied Biosystems, Inc. (Inactive)
Amgen, Inc.

RelSci Relationships

4097

Number of Boards

12

Birthday

1940

Age

80

Number of Awards

1

Relationships
RelSci Relationships are individuals Marvin H. Caruthers likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder & General Partner at Boulder Ventures Ltd.

Relationship likelihood: Strong

Chief Scientist at Simons Foundation

Relationship likelihood: Strong

Venture Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

Co-Founder at Array BioPharma Inc.

Relationship likelihood: Strong

Former Chief Executive Officer at Rapt Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Innoviva, Inc.

Relationship likelihood: Strong

Co-Founder at Arivale, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Miragen Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Genetics Institute LLC

Relationship likelihood: Strong

Director at University of Michigan - Center for Computational Medicine and Bioinformatics

Relationship likelihood: Strong

Paths to Marvin H. Caruthers
Potential Connections via
Relationship Science
You
Marvin H. Caruthers
Distinguished Professor of Chemistry & Biochemistry at The University of Colorado
Education
BS Chemistry

Iowa State is an international university with a friendly welcoming personality. Students from all 50 states and more than 100 countries come to Ames, Iowa, to choose from 100 majors, study with world-class scholars and hone their leadership skills in 800-plus student organizations. Iowa State offers a great environment where students can enjoy reaching their potential and discovering their passions.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. In 1853 the founders purchased a 379-acre tract of land on the shore of Lake Michigan 12 miles north of Chicago. They established a campus and developed the land near it, naming the surrounding town Evanston in honor of one of the University's founders, John Evans. After completing its first building, its first building in 1855, Northwestern began classes that fall with two faculty members and 10 students. Northwestern has three campuses and a total of 12 Schools and Colleges (one of which is located in South Florida. Two campuses are located on Lake Michigan, a 240-acre campus in Evanston, the first suburb north of Chicago, and a 25-acre campus in Chicago. One campus is located in Doha, Qatar. Northwestern University combines innovative teaching and pioneering research in a highly collaborative environment that transcends traditional academic boundaries. It provides students and faculty exceptional opportunities for intellectual, personal and professional growth in a setting enhanced by the richness of Chicago.

Post-Doctoral Studies

Massachusetts Institute of Technology (MIT) is a private research university located in Cambridge, Massachusetts, United States. MIT has five schools and one college, containing a total of 32 academic departments, with a strong emphasis on scientific, engineering, and technological education and research. Founded in 1861 in response to the increasing industrialization of the United States, the institute used a polytechnic university model and stressed laboratory instruction. MIT was elected to the Association of American Universities in 1934.

Memberships
Member
Current

The National Academy of Sciences (NAS) formed the Committee on International Security and Arms Control (CISAC) in 1980 as a permanent committee to bring the resources of the Academy to bear on critical problems of international security and arms control. CISAC, in the Policy and Global Affairs Division, draws from the nation’s finest scientific, technical, engineering and medical talent to advise the government, contribute to the work of non-governmental organizations, and inform the public about scientific and technical issues related to international security and arms control. CISAC’s work benefits from a rotating membership of distinguished scientists, policy and military experts. The Committee carries out its mandate through a variety of activities that receive financial support from public and private sponsors.

Member
Current

Founded in 1780, the American Academy of Arts and Sciences is an independent policy research center that conducts multidisciplinary studies of complex and emerging problems. The Academy’s elected members are leaders in the academic disciplines, the arts, business, and public affairs. With a current membership of 4,000 American Fellows and 600 Foreign Honorary Members, the Academy has four major goals: Promoting service and study through analysis of critical social and intellectual issues and the development of practical policy alternatives; Fostering public engagement and the exchange of ideas with meetings, conferences, and symposia bringing diverse perspectives to the examination of issues of common concern; Mentoring a new generation of scholars and thinkers through the Visiting Scholars Program and Hellman Fellowship Program; Honoring excellence by electing to membership men and women in a broad range of disciplines and professions. Click here to learn about our new members. The Academy's headquarters are in Cambridge, Massachusetts. With its geographically diverse membership, it conducts activities in this country and abroad

Career History
Distinguished Professor of Chemistry & Biochemistry
Current

The University of Colorado advances the economy, health and culture of Colorado and beyond, educating more than 435,000 students who have become catalysts in business, arts, health and community growth. CU’s four campuses feature top-tier faculty and hands-on learning opportunities in an environment where students thrive.

Co-Founder
2007 - Prior

miRagen Therapeutics, Inc. develops microRNA-based therapeutics for cardiovascular and muscle diseases. It leverages in-house expertise in miRNA biology, oligonucleotide chemistry, and drug development to evaluate and advance RNA-based technologies and potential drug candidates for its own pipeline and in strategic collaborations. The firm aso focuses on hematological malignancies, fibrosis and neuro inflammation. The company was founded by William S. Marshall, Michael R. Bristow, Marvin H. Caruthers, Bruce Lee Booth and Eric Newell Olson in 2007 and is headquartered in Boulder, CO.

Venture Partner
1995 - Prior

Boulder Ventures focuses on equity investments in early-stage and emerging-growth technology companies, primarily in the information technology and life sciences sectors. About 75% of their investments are in information technology companies and about 25% of their investments are in life sciences companies. The firm invests in companies throughout the US.Within the information technology sector, Boulder Ventures focuses on the following areas: software, Internet-based business applications and services, information management and communications infrastructure and services. They look for companies with products that target large and fast-growing markets, improve quality, lower costs, speed up processes, increase productivity and provide a platform for new services. Boulder Ventures also looks for companies that expand the need to move and utilize information. In addition, they are particularly interested in service companies that use the Internet to streamline business-to-business activities.Within the life sciences sector, Boulder Ventures focuses on investments in life sciences tools, platforms, software, services and healthcare.Boulder Ventures generally serves as the lead investor in the deal in which they participate. Initial investments range from $1 million to $4 million. The firm typically invests from $5 million to $10 million over the life of a company. They also expect to provide follow-on capital in later rounds of equity financing. In addition, Boulder Ventures can arrange mezzanine financing, bank loans, leasing and other capital. They also represent and advise their portfolio companies throughout the exit process which may include a sale or IPO.

Boards & Committees
Member, Scientific Advisory Board
Prior

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$5,000 +
2009

TO ENHANCE THE QUALITY AND AVAILABILITY OF HEALTH CARE SERVICES IN BOULDER COUNTY.

$5,000 +
2008

TO ENHANCE THE QUALITY AND AVAILABILITY OF HEALTH CARE SERVICES IN BOULDER COUNTY.

Political Donations
$500
1996

Former President at The College of William & Mary

Investments
Details Hidden

Genomica Corp. provided software products and services for the pharmaceutical and biotechnology industries. The company was headquartered in Boulder, CO.

Details Hidden

GE Healthcare Dharmacon, Inc. engages in the research and development for ribonucleic acid synthesis. Its products are gene editing, RNA interference, cDNAs and ORFs, transfection, and viral packaging. The company was founded by Stephen Scaringe in 1995 and is headquartered in Lafayette, CO.

Awards & Honors
Guggenheim Fellowship
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Marvin H. Caruthers. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Marvin H. Caruthers's profile does not indicate a business or promotional relationship of any kind between RelSci and Marvin H. Caruthers.